CS
SUPN icon

Candriam SCA’s Supernus Pharmaceuticals SUPN Stock Holding History

Candriam SCA’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,964
Closed -$2M – 720
2025
Q1 		$2M Sell
60,964
-48,363
-44% -$1.71M 0.01% 495
2024
Q4 		$3.95M Sell
109,327
-32,562
-23% -$1.15M 0.02% 391
2024
Q3 		$4.42M Hold
141,889
– – 0.03% 384
2024
Q2 		$3.8M Buy
+141,889
New +$4.11M 0.02% 383
2020
Q4 		– Sell
-20,000
Closed -$417K – 846
2020
Q3 		$417K Sell
20,000
-14,000
-41% -$318K ﹤0.01% 726
2020
Q2 		$808K Sell
34,000
-159,000
-82% -$3.51M 0.01% 633
2020
Q1 		$4.47M Hold
193,000
– – 0.05% 379
2019
Q4 		$4.58M Sell
193,000
-99,000
-34% -$2.4M 0.05% 387
2019
Q3 		$8.02M Buy
292,000
+7,000
+2% +$207K 0.11% 227
2019
Q2 		$9.39M Buy
285,000
+75,000
+36% +$2.57M 0.12% 201
2019
Q1 		$7.36M Buy
210,000
+75,000
+56% +$2.79M 0.09% 244
2018
Q4 		$4.49M Buy
+135,000
New +$5.81M 0.07% 300
2017
Q4 		– Sell
-89,000
Closed -$3.56M – 775
2017
Q3 		$3.56M Buy
89,000
+18,000
+25% +$779K 0.06% 340
2017
Q2 		$3.06M Sell
71,000
-61,000
-46% -$2.17M 0.06% 379
2017
Q1 		$4.13M Buy
132,000
+45,000
+52% +$1.21M 0.08% 289
2016
Q4 		$2.2M Buy
+87,000
New +$1.94M 0.05% 353
2015
Q1 		– Sell
-63,000
Closed -$523K – 659
2014
Q4 		$523K Buy
+63,000
New +$529K 0.01% 514

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Candriam SCA's SUPN Position: Q2 2025 in Review

Candriam SCA sold out of Supernus Pharmaceuticals (SUPN) in Q2 2025, closing a stake of 60,964 shares — an estimated $2M sold.

Candriam SCA first reported a position in SUPN in Q4 2014 and held it in 17 quarters. The position peaked at $9.39M in Q2 2019. 295 funds tracked by Wall St. Rank hold SUPN as of Q2 2025.

  • Candriam SCA reported no remaining Supernus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Candriam SCA sold 60,964 Supernus Pharmaceuticals shares in Q2 2025, an estimated $2M.
  • Candriam SCA first reported a position in Supernus Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Candriam SCA's Supernus Pharmaceuticals position peaked at $9.39M in Q2 2019.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2025.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.